[Pulmonary hypertension in patients infected with human immunodeficiency virus: current situation].
The increase in survival that has been achieved with the new treatments in the era of highly active antiretroviral therapy, has enabled clinicians and researchers to analyze issues that emerge in the long term in patients with HIV infection. Although the majority of cardiovascular complications have been widely described, the pathogenesis of pulmonary arterial hypertension is still poorly understood, and is one of the more complex and feared complications as it worsens the prognosis and quality of life of these patients This article reviews newer aspects related to the aetiology, symptoms, diagnosis and treatment of this disease.
Servicio de Medicina Interna, Unidad de Enfermedades Infecciosas y Microbiología Clínica, Grupo Multidisciplinar de Hipertensión Pulmonar, Hospital Universitario La Paz, Madrid, España. clarasoto27@gmail.com
Clara Itzíar
CI
Soto-Abánades
Sergio
S
Alcolea-Batres
Juan José
JJ
Ríos-Blanco
D000465:Algorithms; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*